192 related articles for article (PubMed ID: 27981412)
1. Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication.
Weil AG; Wang AC; Westwick HJ; Ibrahim GM; Ariani RT; Crevier L; Perreault S; Davidson T; Tseng CH; Fallah A
J Neurooncol; 2017 Mar; 132(1):99-107. PubMed ID: 27981412
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and secondary malignancies in childhood medulloblastoma.
Stavrou T; Bromley CM; Nicholson HS; Byrne J; Packer RJ; Goldstein AM; Reaman GH
J Pediatr Hematol Oncol; 2001 Oct; 23(7):431-6. PubMed ID: 11878577
[TBL] [Abstract][Full Text] [Related]
3. Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome.
Brasme JF; Grill J; Doz F; Lacour B; Valteau-Couanet D; Gaillard S; Delalande O; Aghakhani N; Puget S; Chalumeau M
PLoS One; 2012; 7(4):e33415. PubMed ID: 22485143
[TBL] [Abstract][Full Text] [Related]
4. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
[TBL] [Abstract][Full Text] [Related]
5. Evidence of high mortality in long term survivors of childhood medulloblastoma.
Ning MS; Perkins SM; Dewees T; Shinohara ET
J Neurooncol; 2015 Apr; 122(2):321-7. PubMed ID: 25557108
[TBL] [Abstract][Full Text] [Related]
6. Infants with medulloblastoma: a single institution review of survival.
Geyer R; Levy M; Berger MS; Milstein J; Griffin B; Bleyer WA
Neurosurgery; 1991 Nov; 29(5):707-10; discussion 710-1. PubMed ID: 1961400
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and abandonment and outcome of treatment in 67 Chinese children with medulloblastoma.
Wang C; Yuan XJ; Jiang MW; Wang LF
J Neurosurg Pediatr; 2016 Jan; 17(1):49-56. PubMed ID: 26451721
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with adult medulloblastoma: a population-based study.
Lai R
Cancer; 2008 Apr; 112(7):1568-74. PubMed ID: 18278809
[TBL] [Abstract][Full Text] [Related]
9. Importance of radiation time and dose factors on outcome for childhood medulloblastoma.
Back M; Ahern V; Berry M; Borg M; Sexton M; Cameron F; Stevens G; Allison R; Childs J; Barton M
Australas Radiol; 2005 Aug; 49(4):298-303. PubMed ID: 16026436
[TBL] [Abstract][Full Text] [Related]
10. Late Morbidity and Mortality Among Medulloblastoma Survivors Diagnosed Across Three Decades: A Report From the Childhood Cancer Survivor Study.
Salloum R; Chen Y; Yasui Y; Packer R; Leisenring W; Wells E; King A; Howell R; Gibson TM; Krull KR; Robison LL; Oeffinger KC; Fouladi M; Armstrong GT
J Clin Oncol; 2019 Mar; 37(9):731-740. PubMed ID: 30730781
[TBL] [Abstract][Full Text] [Related]
11. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
12. Adult medulloblastoma: an analysis of survival and prognostic factors.
Le QT; Weil MD; Wara WM; Lamborn KR; Prados MD; Edwards MS; Gutin PH
Cancer J Sci Am; 1997; 3(4):238-45. PubMed ID: 9263630
[TBL] [Abstract][Full Text] [Related]
13. [Medulloblastoma: improved survival in recent decades. Unicentric experience].
Igual Estellés L; Berlanga Charriel P; Cañete Nieto A
An Pediatr (Barc); 2017 Jan; 86(1):4-10. PubMed ID: 27068068
[TBL] [Abstract][Full Text] [Related]
14. A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma.
Gerber NU; von Hoff K; von Bueren AO; Treulieb W; Deinlein F; Benesch M; Zwiener I; Soerensen N; Warmuth-Metz M; Pietsch T; Mittler U; Kuehl J; Kortmann RD; Grotzer MA; Rutkowski S
Eur J Cancer; 2012 Sep; 48(13):2028-36. PubMed ID: 22153558
[TBL] [Abstract][Full Text] [Related]
15. Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis.
Nantavithya C; Paulino AC; Liao K; McGovern SL; Grosshans DR; McAleer MF; Woodhouse KD; Khatua S; Chintagumpala MM; Majd NK; Yeboa DN
Pediatr Blood Cancer; 2020 Aug; 67(8):e28373. PubMed ID: 32453481
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma--a review of prognosis and survival.
McFarland DR; Horwitz H; Saenger EL; Bahr GK
Br J Radiol; 1969 Mar; 42(495):198-214. PubMed ID: 5765696
[No Abstract] [Full Text] [Related]
17. The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy).
Vivekanandan S; Breene R; Ramanujachar R; Traunecker H; Pizer B; Gaze MN; Saran F; Thorp N; English M; Wheeler KA; Michalski A; Walker DA; Saunders D; Cowie F; Cameron A; Picton SV; Parashar D; Horan G; Williams MV
Pediatr Blood Cancer; 2015 Dec; 62(12):2132-9. PubMed ID: 26274622
[TBL] [Abstract][Full Text] [Related]
18. Long-term life expectancy for children with ependymoma and medulloblastoma.
Frandsen JE; Wagner A; Bollo RJ; Shrieve DC; Poppe MM
Pediatr Blood Cancer; 2015 Nov; 62(11):1986-91. PubMed ID: 26017317
[TBL] [Abstract][Full Text] [Related]
19. Survival Following Tumor Recurrence in Children With Medulloblastoma.
Johnston DL; Keene D; Strother D; Taneva M; Lafay-Cousin L; Fryer C; Scheinemann K; Carret AS; Fleming A; Afzal S; Wilson B; Bowes L; Zelcer S; Mpofu C; Silva M; Larouche V; Brossard J; Bouffet E
J Pediatr Hematol Oncol; 2018 Apr; 40(3):e159-e163. PubMed ID: 29432312
[TBL] [Abstract][Full Text] [Related]
20. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
Massimino M; Antonelli M; Gandola L; Miceli R; Pollo B; Biassoni V; Schiavello E; Buttarelli FR; Spreafico F; Collini P; Giangaspero F
Pediatr Blood Cancer; 2013 Feb; 60(2):210-6. PubMed ID: 22693015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
